Kathi Apostolidis
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Kathi Apostolidis
Feb 19, 2024, 14:51 |
Blog
Kathi Apostolidis: An impressively large and very promising project to study the immune system was announced
Kathi Apostolidis shared the following post by Davorka Sekulic, Medical Lead Immunology at Sanofi, on…
Oct 28, 2023, 15:53 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 10
Our 2023 OncoDaily series on '100 Influential Women in Oncology: Key Opinion Leaders to Follow…
Jul 16, 2023, 07:02 |
Stories
Let's hope that all liposarcoma patients and their doctors will hear all about the clinical trial Brightline - Kathi Apostolidis
This is encouraging news for patients with a very rare cancer, liposarcoma, who had not…
All:
3
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube